Factors Affecting Dissolution Rate of Sulpiride from Tablets Coated with Polyvinylacetal Diethylaminoacetate, a Gastric-Fluid-Soluble Polymer. I. Effect of Ionic Strength of Gastrointestinal Fluids
The bioavailability of sulpiride (SP) from a tablet coated with AEA [○!R] (polyvinylacetal diethylaminoacetate), used as a gastric-fluid-soluble polymer, is very poor in low gastric acidity subjects in the fasting state but improves after food intake. To analyze the factors affecting SP bioavailabil...
Saved in:
Published in | Chemical & pharmaceutical bulletin Vol. 43; no. 7; pp. 1204 - 1211 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Tokyo
The Pharmaceutical Society of Japan
15.07.1995
公益社団法人日本薬学会 Maruzen Japan Science and Technology Agency |
Subjects | |
Online Access | Get full text |
ISSN | 0009-2363 1347-5223 |
DOI | 10.1248/cpb.43.1204 |
Cover
Abstract | The bioavailability of sulpiride (SP) from a tablet coated with AEA [○!R] (polyvinylacetal diethylaminoacetate), used as a gastric-fluid-soluble polymer, is very poor in low gastric acidity subjects in the fasting state but improves after food intake. To analyze the factors affecting SP bioavailability from an AEA [○!R] film-coated tablet (AEA [○!R] tablet), we prepared AEA [○!R] cast film and AEA [○!R] tablets and investigated the physicochemical properties of gastrointestinal (GI) fluids affecting the dissolution of the film coating and the dissolution rate of SP from the tablets. The dissolution time of AEA [○!R] cast film was shortened with an increase in the ionic strength of the medium, but was delayed by an increase in viscosity and addition of sodium taurocholate to the medium. The AEA [○!R] tablet showed rapid dissolution of SP at pH 4 or below but not when the pH was 5.0 or above. In pH 5.0-5.8 media, the SP dissolution rate from the tablet increased as the ionic strength (μ) of the medium rose, reaching maximum at μ=0.3. Microscopic observations and measurements of film coating thickness revealed that the increased dissolution rate of SP from the tablet with higher ionic strength (μ=0.3) was due to promotion of the dissolution of the AEA [○!R] film coating. Data from pH titration showed that increased ionic strength (μ=0.3) resulted in higher apparent dissociation, which increased the solubility of AEA [○!R] in the medium. We concluded that the ionic strength in GI fluids is one of the factors affecting the bioavailability from AEA [○!R] tablet. After food intake, the bioavailability of SP from the tablet improves, probably due to increased apparent dissociation of AEA [○!R] caused by an increase in ionic strength from the meal (ca. μ=0.3). This increases the dissolution rate of the film coating and thus, the dissolution rate of SP from the AEA [○!R] tablet, leading to enhanced absorption. |
---|---|
AbstractList | The bioavailability of sulpiride (SP) from a tablet coated with AEA [○!R] (polyvinylacetal diethylaminoacetate), used as a gastric-fluid-soluble polymer, is very poor in low gastric acidity subjects in the fasting state but improves after food intake. To analyze the factors affecting SP bioavailability from an AEA [○!R] film-coated tablet (AEA [○!R] tablet), we prepared AEA [○!R] cast film and AEA [○!R] tablets and investigated the physicochemical properties of gastrointestinal (GI) fluids affecting the dissolution of the film coating and the dissolution rate of SP from the tablets. The dissolution time of AEA [○!R] cast film was shortened with an increase in the ionic strength of the medium, but was delayed by an increase in viscosity and addition of sodium taurocholate to the medium. The AEA [○!R] tablet showed rapid dissolution of SP at pH 4 or below but not when the pH was 5.0 or above. In pH 5.0-5.8 media, the SP dissolution rate from the tablet increased as the ionic strength (μ) of the medium rose, reaching maximum at μ=0.3. Microscopic observations and measurements of film coating thickness revealed that the increased dissolution rate of SP from the tablet with higher ionic strength (μ=0.3) was due to promotion of the dissolution of the AEA [○!R] film coating. Data from pH titration showed that increased ionic strength (μ=0.3) resulted in higher apparent dissociation, which increased the solubility of AEA [○!R] in the medium. We concluded that the ionic strength in GI fluids is one of the factors affecting the bioavailability from AEA [○!R] tablet. After food intake, the bioavailability of SP from the tablet improves, probably due to increased apparent dissociation of AEA [○!R] caused by an increase in ionic strength from the meal (ca. μ=0.3). This increases the dissolution rate of the film coating and thus, the dissolution rate of SP from the AEA [○!R] tablet, leading to enhanced absorption. The bioavailability of sulpiride (SP) from a tablet coated with AEA [[white circle]!R] (polyvinylacetal diethylaminoacetate), used as a gastric-fluid-soluble polymer, is very poor in low gastric acidity subjects in the fasting state but improves after food intake. To analyze the factors affecting SP bioavailability from an AEA [[white circle]!R] film-coated tablet (AEA [[white circle]!R] tablet), we prepared AEA [[white circle]!R] cast film and AEA [[white circle]!R] tablets and investigated the physicochemical properties of gastrointestinal (GI) fluids affecting the dissolution of the film coating and the dissolution rate of SP from the tablets. The dissolution time of AEA [[white circle]!R] cast film was shortened with an increase in the ionic strength of the medium, but was delayed by an increase in viscosity and addition of sodium taurocholate to the medium. The AEA [[white circle]!R] tablet showed rapid dissolution of SP at pH 4 or below but not when the pH was 5.0 or above. In pH 5.0-5.8 media, the SP dissolution rate from the tablet increased as the ionic strength (μ) of the medium rose, reaching maximum at μ=0.3. Microscopic observations and measurements of film coating thickness revealed that the increased dissolution rate of SP from the tablet with higher ionic strength (μ=0.3) was due to promotion of the dissolution of the AEA [[white circle]!R] film coating. Data from pH titration showed that increased ionic strength (μ=0.3) resulted in higher apparent dissociation, which increased the solubility of AEA [[white circle]!R] in the medium. We concluded that the ionic strength in GI fluids is one of the factors affecting the bioavailability from AEA [[white circle]!R] tablet. After food intake, the bioavailability of SP from the tablet improves, probably due to increased apparent dissociation of AEA [[white circle]!R] caused by an increase in ionic strength from the meal (ca. μ=0.3). This increases the dissolution rate of the film coating and thus, the dissolution rate of SP from the AEA [[white circle]!R] tablet, leading to enhanced absorption. |
Author | TAMURA, Shigeki SHINKUMA, Denji HAMAGUCHI, Tsuneo MIZUNO, Nobuyasu YAMANAKA, You MIYAKE, Masatoshi |
Author_FL | SHINKUMA Denji MIYAKE Masatoshi HAMAGUCHI Tsuneo MIZUNO Nobuyasu TAMURA Shigeki YAMANAKA You |
Author_FL_xml | – sequence: 1 fullname: HAMAGUCHI Tsuneo – sequence: 2 fullname: SHINKUMA Denji – sequence: 3 fullname: YAMANAKA You – sequence: 4 fullname: MIYAKE Masatoshi – sequence: 5 fullname: TAMURA Shigeki – sequence: 6 fullname: MIZUNO Nobuyasu |
Author_xml | – sequence: 1 fullname: YAMANAKA, You – sequence: 1 fullname: MIZUNO, Nobuyasu – sequence: 1 fullname: TAMURA, Shigeki – sequence: 1 fullname: HAMAGUCHI, Tsuneo – sequence: 1 fullname: MIYAKE, Masatoshi – sequence: 1 fullname: SHINKUMA, Denji |
BackLink | https://cir.nii.ac.jp/crid/1570009752440589824$$DView record in CiNii http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3645777$$DView record in Pascal Francis |
BookMark | eNpFUV1vEzEQtFCRSAtP_AFL8MgFf57vHqu0KZEqgUh5Pjm-vcSRYwfbV5QfyP_CuVT0Ze3dnZ0Zaa7RlQ8eEPpIyZwy0Xw1x81c8PIn4g2aUS5UJRnjV2hGCGkrxmv-Dl2ntCeESaL4DP1dapNDTPh2GMBk67f4zqYU3Jht8PinzoDDgNejO9poe8BDDAf8pDcOcsKLUPY9_mPzDv8I7vRs_clpA1m7QgN5V7qD9WEaZfiCNX7QKUdrqqUbbV-ti1Chmo4PEOd4Ncf3k5Oz6ip4a_A6R_DbolAm03WwPkMqXovKRJPeo7eDdgk-vLw36Nfy_mnxrXr8_rBa3D5We0ZlrpQW3Mh-IIYKXdcwtC2Vimm2YUZT1tON4r1qgQlGG2XMwDlAzySDXtUDB36DPl14jzH8HouHbh_GWHykjoqasFooWRfU5xeUTka7IWpvbOqO0R50PHW8FlIp9Qrz1nbGnmtxcw5KSSYEkU3bMFFgdxfYPmW9hf80OmZrHHQlc9rKphO8U5dyjv91vdOxA8__AQVOrCE |
CODEN | CPBTAL |
ContentType | Journal Article |
Copyright | The Pharmaceutical Society of Japan 1995 INIST-CNRS Copyright Japan Science and Technology Agency 1995 |
Copyright_xml | – notice: The Pharmaceutical Society of Japan – notice: 1995 INIST-CNRS – notice: Copyright Japan Science and Technology Agency 1995 |
DBID | RYH IQODW 7TK 7TM 7U9 H94 K9. |
DOI | 10.1248/cpb.43.1204 |
DatabaseName | CiNii Complete Pascal-Francis Neurosciences Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) |
DatabaseTitle | AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Virology and AIDS Abstracts Neurosciences Abstracts Nucleic Acids Abstracts |
DatabaseTitleList | AIDS and Cancer Research Abstracts |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1347-5223 |
EndPage | 1211 |
ExternalDocumentID | 3133001651 3645777 110003631635 article_cpb1958_43_7_43_7_1204_article_char_en |
GroupedDBID | --- .55 2WC 53G 5GY 6J9 ACGFO ACIWK ACPRK ADBBV AENEX AFRAH AI. ALMA_UNASSIGNED_HOLDINGS BAWUL CS3 DIK DU5 EBS EJD F5P GX1 HH5 JSF JSH KQ8 L7B OK1 P2P RJT RZJ TKC TR2 VH1 X7M ZGI ZY4 RYH .GJ 29B 3O- BKOMP E3Z IQODW JMI MOJWN X7J XSB ZE2 7TK 7TM 7U9 H94 K9. |
ID | FETCH-LOGICAL-j215t-7a43c5df0c14a66ef991572a2b2ca12d1b73d79e242187ccf33eed252ed76f3e3 |
ISSN | 0009-2363 |
IngestDate | Sat Sep 20 14:11:57 EDT 2025 Mon Jul 21 09:16:19 EDT 2025 Thu Jun 26 22:54:31 EDT 2025 Wed Sep 03 06:26:30 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | Phosphates Stomach Pharmaceutical technology Control release polymer Psychotropic Bile salt Acetate Bioavailability Buffer solution Dissolution In vitro Vinyl acetate polymer Medium effect Ionic strength Antisecretory agent Dosage form pH Active ingredient Kinetics Aqueous solution Coated tablet Release Physicochemical properties |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-j215t-7a43c5df0c14a66ef991572a2b2ca12d1b73d79e242187ccf33eed252ed76f3e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/cpb1958/43/7/43_7_1204/_article/-char/en |
PQID | 1460264756 |
PQPubID | 1996362 |
PageCount | 8 |
ParticipantIDs | proquest_journals_1460264756 pascalfrancis_primary_3645777 nii_cinii_1570009752440589824 jstage_primary_article_cpb1958_43_7_43_7_1204_article_char_en |
PublicationCentury | 1900 |
PublicationDate | 1995-07-15 |
PublicationDateYYYYMMDD | 1995-07-15 |
PublicationDate_xml | – month: 07 year: 1995 text: 1995-07-15 day: 15 |
PublicationDecade | 1990 |
PublicationPlace | Tokyo |
PublicationPlace_xml | – name: Tokyo |
PublicationTitle | Chemical & pharmaceutical bulletin |
PublicationTitleAlternate | Chem. Pharm. Bull. |
PublicationTitle_FL | Chem. Pharm. Bull |
PublicationYear | 1995 |
Publisher | The Pharmaceutical Society of Japan 公益社団法人日本薬学会 Maruzen Japan Science and Technology Agency |
Publisher_xml | – name: The Pharmaceutical Society of Japan – name: 公益社団法人日本薬学会 – name: Maruzen – name: Japan Science and Technology Agency |
References | 12) "Catalog of HPMCP," Shinetsu Chemical Co., Ltd., Tokyo, 1991, p. 2. 6) Shinkuma D., Hamaguchi T., Kobayashi M., Yamanaka Y., Mizuno N., Int. J. Clin. Pharmacol. Ther. Toxicol., 29, 303 (1991). 14) Ogata H., Shibazaki T., Inoue T., Ejima A., J. Pharm. Sci., 68, 708 (1979). 8) Hayashi M., Nagai T., Nogami H., Chem. Pharm. Bull., 18, 2350 (1970). 10) Mizuno N., Shimizu C., Morita E., Shinkuma D., Yamanaka Y., Yakuzaigaku, 43, 209 (1983). 11) Tomida Y., Yokohama S., Maki M., Toguchi H., Shimamoto T., J. Takeda Res. Lab., 36, 83 (1977). 9) Sjoqvist R., Nyqvist H., Sjovall J., Westerlund D., J. Micro-encapsulation, 2, 123 (1985). 1) Ogata H., Aoyagi N., Kaniwa N., Shibazaki T., Ejima E., Takagishi Y., Ogura T., Tomita K., Inoue S., Zaizen M., Int. J. Pharmaceut., 23, 277 (1985). 5) Shinkuma D., Hamaguchi T., Kobayashi M., Yamanaka Y., Mizuno N., Int. J. Clin. Pharmacol. Ther. Toxicol., 28,440 (1990). 7) "Catalog of AEA, Sankyo," Sankyo K.K., Tokyo, 1987, pp. 6-7. 4) Shinkuma D., Hamaguchi T., Kobayashi M., Yamanaka Y., Mizuno N., Int. J. Clin. Pharmacol. Ther. Toxicol., 27, 499 (1989). 13) Ogata H., Shibazaki T., Inoue T., Ejima A., J. Pharm. Sci., 68, 712 (1979). 15) Armand J.Y., Magnard F., Bouzon J., Rollet J., Taverdet J.L., Vergnaud J.M., Int. J. Pharmaceut., 40, 33 (1987). 3) Shinkuma D., Hamaguchi T., Kobayashi M., Yamanaka Y., Mizuno N., Yakuzaigaku, 48, 106 (1988). 2) Aoyagi N., Ogata H., Kaniwa N., Koibuchi M., Shibazaki T., Ejima A., Mizobe M., Kohno K., Samejima M., Chem. Pharm. Bull., 34, 281 (1986). |
References_xml | – reference: 6) Shinkuma D., Hamaguchi T., Kobayashi M., Yamanaka Y., Mizuno N., Int. J. Clin. Pharmacol. Ther. Toxicol., 29, 303 (1991). – reference: 1) Ogata H., Aoyagi N., Kaniwa N., Shibazaki T., Ejima E., Takagishi Y., Ogura T., Tomita K., Inoue S., Zaizen M., Int. J. Pharmaceut., 23, 277 (1985). – reference: 15) Armand J.Y., Magnard F., Bouzon J., Rollet J., Taverdet J.L., Vergnaud J.M., Int. J. Pharmaceut., 40, 33 (1987). – reference: 4) Shinkuma D., Hamaguchi T., Kobayashi M., Yamanaka Y., Mizuno N., Int. J. Clin. Pharmacol. Ther. Toxicol., 27, 499 (1989). – reference: 9) Sjoqvist R., Nyqvist H., Sjovall J., Westerlund D., J. Micro-encapsulation, 2, 123 (1985). – reference: 10) Mizuno N., Shimizu C., Morita E., Shinkuma D., Yamanaka Y., Yakuzaigaku, 43, 209 (1983). – reference: 13) Ogata H., Shibazaki T., Inoue T., Ejima A., J. Pharm. Sci., 68, 712 (1979). – reference: 7) "Catalog of AEA, Sankyo," Sankyo K.K., Tokyo, 1987, pp. 6-7. – reference: 2) Aoyagi N., Ogata H., Kaniwa N., Koibuchi M., Shibazaki T., Ejima A., Mizobe M., Kohno K., Samejima M., Chem. Pharm. Bull., 34, 281 (1986). – reference: 11) Tomida Y., Yokohama S., Maki M., Toguchi H., Shimamoto T., J. Takeda Res. Lab., 36, 83 (1977). – reference: 12) "Catalog of HPMCP," Shinetsu Chemical Co., Ltd., Tokyo, 1991, p. 2. – reference: 14) Ogata H., Shibazaki T., Inoue T., Ejima A., J. Pharm. Sci., 68, 708 (1979). – reference: 3) Shinkuma D., Hamaguchi T., Kobayashi M., Yamanaka Y., Mizuno N., Yakuzaigaku, 48, 106 (1988). – reference: 8) Hayashi M., Nagai T., Nogami H., Chem. Pharm. Bull., 18, 2350 (1970). – reference: 5) Shinkuma D., Hamaguchi T., Kobayashi M., Yamanaka Y., Mizuno N., Int. J. Clin. Pharmacol. Ther. Toxicol., 28,440 (1990). |
SSID | ssj0025073 |
Score | 1.4744102 |
Snippet | The bioavailability of sulpiride (SP) from a tablet coated with AEA [○!R] (polyvinylacetal diethylaminoacetate), used as a gastric-fluid-soluble polymer, is... The bioavailability of sulpiride (SP) from a tablet coated with AEA ^<[○!R]> (polyvinylacetal diethylaminoacetate), used as a gastric-fluid-soluble polymer, is... The bioavailability of sulpiride (SP) from a tablet coated with AEA [[white circle]!R] (polyvinylacetal diethylaminoacetate), used as a gastric-fluid-soluble... |
SourceID | proquest pascalfrancis nii jstage |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1204 |
SubjectTerms | AEA [○!R] Biological and medical sciences dissociation dissolution rate film-coated tablet General pharmacology ionic strength Medical sciences Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments sulpiride |
Title | Factors Affecting Dissolution Rate of Sulpiride from Tablets Coated with Polyvinylacetal Diethylaminoacetate, a Gastric-Fluid-Soluble Polymer. I. Effect of Ionic Strength of Gastrointestinal Fluids |
URI | https://www.jstage.jst.go.jp/article/cpb1958/43/7/43_7_1204/_article/-char/en https://cir.nii.ac.jp/crid/1570009752440589824 https://www.proquest.com/docview/1460264756 |
Volume | 43 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Chemical and Pharmaceutical Bulletin, 1995/07/15, Vol.43(7), pp.1204-1211 |
journalDatabaseRights | – providerCode: PRVFSB databaseName: Free Full-Text Journals in Chemistry customDbUrl: eissn: 1347-5223 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0025073 issn: 0009-2363 databaseCode: HH5 dateStart: 19580101 isFulltext: true titleUrlDefault: http://abc-chemistry.org/ providerName: ABC ChemistRy – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1347-5223 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0025073 issn: 0009-2363 databaseCode: KQ8 dateStart: 19580101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1347-5223 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0025073 issn: 0009-2363 databaseCode: DIK dateStart: 19580101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1347-5223 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0025073 issn: 0009-2363 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Nb9MwFLfWceGC-BQdG_IB7dImNJ9uDxyqQddu2ihbK01cIidxtoyRTG2CVP4__i_es530gx4YXKzIieMk7_3sn533Qcg7bouoG2IOQBY6hgtTKBy5iYH0IEqc2A1lUJ-zc384dU-uvKudhrVitVQWoRn93OpX8i9ShTqQK3rJPkCy9U2hAo5BvlCChKH8KxkPdLKcvjTKwEX_x7TusnXBlQnAJSYYnqWxUL4kE3SWKjBVJy8q2_Nxfrf4kWYL3FMv5EAoQICgLGmWyyqVRI-3jjnm-YiMwV2ZxgbuqaHnFTb_LmZma2S2dDhk9FCRyXXwt3d2DX1AjWydY4QKGFiQBsvbzFcJ8loAg_HN2ob7WqhwHKn6mI_gtC-nkbysdWf0dXr-Wf2UCssFn9dnJv2z6YW8_PImvRbf0lqp4U7H06PhSKrvvMxEvtwOUe7lzFAOoWblULfxcJX5K7zmCRCQbG066Bm2o0dYoWYAx2WwOldO0NUUoSJJaSiwlfHeslXyZM0dMF7e1nnJdtHXIroPTdcxl43WAn1rNQrgKowAFLhOwFSBDYL6NLwdKH-DPLKZ72PSjtMv9Y8zILSsTh6Ib6ZdUqH_9yu9A926hcUHRpVoZGmKBsF8Dt8qUclc_uAlkmxNnpInepVE--phnpEdkT0nh_qLL9p0svQanLfpIR0vA7AvXpBfGhe0xgVdwQVFXNA8oTUuKOKCalxQhQuKuKAbuKBbcNGmnG5FBa1QQUcmVajAXiUqaIUKrNlEBVWoeEmmg0-To6Gh05UYt8CbC4Nx14m8OOlElst9XySw9PKYze3Qjrhlx1bInJj1BBphdFkEI6EDBNX2bBEzP3GE84rsZnkmXhPqxKACvThKLOG7sd_tAmsPOfCSrvB4wqIm-aDkF9yrmDTBw5SnSQ5A7EGUYmlhiotOj3nA9DHJaNd24fyaQtTdoNECY6xJ9isFCfR4OMdNhA4sr5jn7_3n470hj5fQ3ie7xawUB8D9i_Ct1Pbfon4Pfw |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Factors+Affecting+Dissolution+Rate+of+Sulpiride+from+Tablets+Coated+with+Polyvinylacetal+Diethylaminoacetate%2C+a+Gastric-Fluid-Soluble+Polymer.+I.+Effect+of+Ionic+Strength+of+Gastrointestinal+Fluids&rft.jtitle=Chemical+and+Pharmaceutical+Bulletin&rft.au=YAMANAKA%2C+You&rft.au=MIZUNO%2C+Nobuyasu&rft.au=TAMURA%2C+Shigeki&rft.au=HAMAGUCHI%2C+Tsuneo&rft.date=1995-07-15&rft.pub=The+Pharmaceutical+Society+of+Japan&rft.issn=0009-2363&rft.eissn=1347-5223&rft.volume=43&rft.issue=7&rft.spage=1204&rft.epage=1211&rft_id=info:doi/10.1248%2Fcpb.43.1204&rft.externalDocID=article_cpb1958_43_7_43_7_1204_article_char_en |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-2363&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-2363&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-2363&client=summon |